Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B
Clinical trial NCT05770895 · COMPLETED
Trial details
- NCT number
- NCT05770895
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2025-01-15
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.